Inhalation Tuesday, October 21, 2014
Skip Navigation LinksHome) Item Details
Inhalation is the only technical publication devoted exclusively to readers involved in development and production of pulmonary or nasal delivered pharmaceuticals.
Technical Articles
High pressure homogenization as an alternative methodology to micronization for obtaining effective inhalation particles

Case studies for the industrial manufacture of inhalation grades of fluticasone propionate and mometasone furoate monohydrate.

One of the key factors affecting delivery of drugs to the lungs is particle size. This is relevant for both dry powder inhaler (DPI) and suspension pressurized metered dose inhaler (pMDI) formulations. Depending upon the specific airway target site, the particle size can vary slightly but generally, an aerodynamic particle size distribution (PSD) of 1-6 µm is required for successful inhalation therapy.

To read this entire article:

You may purchase this article now for personal use. Simply click the Buy Item button above, enter your payment details, and download the article. It will be available to you for 7 days for viewing, printing, or saving for future reference. All articles are copyrighted by CSC Publishing, Inc. and cannot be used for commercial purposes without express permission in writing from the Publisher. This includes but is not limited to: web posting, printing, or sharing via email.

Security:

Your payment information is forwarded in an encrypted form, using 40- or 128-bit Secure Socket Layer technology, only to our payment gateway (Authorize.net) for processing.

Acrobat:

To view an article, you must have Acrobat Reader installed on your computer. Click on the icon to download Acrobat Reader free of charge.

HyperLink
      Copyright 2014, CSC Publishing Inc. ALL Rights Reserved * Privacy policy